[HTML][HTML] CBP/p300: critical co-activators for nuclear steroid hormone receptors and emerging therapeutic targets in prostate and breast cancers
Simple Summary The CREB-binding protein (CBP) and p300 are paralogous lysine
acetyltransferases that serve as critical co-activators for transcription factors involved in …
acetyltransferases that serve as critical co-activators for transcription factors involved in …
Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and disease
A Alendar, A Berns - Genes & Development, 2021 - genesdev.cshlp.org
Chromatin is highly dynamic, undergoing continuous global changes in its structure and
type of histone and DNA modifications governed by processes such as transcription, repair …
type of histone and DNA modifications governed by processes such as transcription, repair …
[HTML][HTML] Cooperative interaction between ERα and the EMT-inducer ZEB1 reprograms breast cancer cells for bone metastasis
N Mohammadi Ghahhari, MK Sznurkowska… - Nature …, 2022 - nature.com
The epithelial to mesenchymal transition (EMT) has been proposed to contribute to the
metastatic spread of breast cancer cells. EMT-promoting transcription factors determine a …
metastatic spread of breast cancer cells. EMT-promoting transcription factors determine a …
[HTML][HTML] The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
Abstract Three-dimensional (3D) epigenome remodeling is an important mechanism of gene
deregulation in cancer. However, its potential as a target to counteract therapy resistance …
deregulation in cancer. However, its potential as a target to counteract therapy resistance …
[HTML][HTML] Estrogen differentially regulates transcriptional landscapes of preoptic and arcuate kisspeptin neuron populations
B Göcz, S Takács, K Skrapits, É Rumpler… - Frontiers in …, 2022 - frontiersin.org
Kisspeptin neurons residing in the rostral periventricular area of the third ventricle (KPRP3V)
and the arcuate nucleus (KPARC) mediate positive and negative estrogen feedback …
and the arcuate nucleus (KPARC) mediate positive and negative estrogen feedback …
[HTML][HTML] Notch signaling in breast tumor microenvironment as mediator of drug resistance
A Chimento, M D'Amico, V Pezzi… - International Journal of …, 2022 - mdpi.com
Notch signaling dysregulation encourages breast cancer progression through different
mechanisms such as stem cell maintenance, cell proliferation and migration/invasion …
mechanisms such as stem cell maintenance, cell proliferation and migration/invasion …
[HTML][HTML] Estrogens: two nuclear receptors, multiple possibilities
A Biason-Lauber, M Lang-Muritano - Molecular and Cellular Endocrinology, 2022 - Elsevier
Much is known about estrogen action in experimental animal models and in human
physiology. This article reviews the mechanisms of estrogen activity in animals and humans …
physiology. This article reviews the mechanisms of estrogen activity in animals and humans …
Prognostic value estimation of BRIP1 in breast cancer by exploiting transcriptomics data through bioinformatics approaches
BRIP1 (Breast Cancer 1 Interacting Helicase 1) is a tumor suppressor gene that has vital
function in preserving the genetic stability by repairing DNA damage though have significant …
function in preserving the genetic stability by repairing DNA damage though have significant …
[HTML][HTML] Breast cancer MCF-7 cell spheroid culture for drug discovery and development
G Chen, W Liu, B Yan - Journal of cancer therapy, 2022 - ncbi.nlm.nih.gov
In vitro 3D cancer spheroids (tumoroids) exhibit a drug resistance profile similar to that found
in solid tumors. 3D spheroid culture methods recreate more physiologically relevant …
in solid tumors. 3D spheroid culture methods recreate more physiologically relevant …
[HTML][HTML] A high-throughput drug screen reveals means to differentiate triple-negative breast cancer
M Vulin, C Jehanno, A Sethi, AL Correia… - Oncogene, 2022 - nature.com
Plasticity delineates cancer subtypes with more or less favourable outcomes. In breast
cancer, the subtype triple-negative lacks expression of major differentiation markers, eg …
cancer, the subtype triple-negative lacks expression of major differentiation markers, eg …